Abstract PS2-10-22: Proteomic analysis of residual disease identifies potential prognostic biomarkers of triple-negative breast cancer after neoadjuvant chemotherapy
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7130731560
Cites:
Cited by:
Related to:
